For an anti-tumor T response to be generated, this process needs to be accompanied by signals that prevent peripheral tolerance to tumor antigens, such as high expression of major histocompatibility complex (MHC) molecules and co-stimulatory molecules (such as CD80, IL1, IFN-α) (27). Here, IL1B is linked to neoplasm.